Clinical trials related to Prostatectomy Procedure
The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy
Status: Recruiting
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The study titled The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy investigates the impact of a structured telemedicine-supported prehabilitation and rehabilitation program on reducing postoperative urinary incontinence in patients with localized prostate cancer. Radical prostatectomy, a common treatment for localized prostate cancer, is often associated with complications such as urinary incontinence, which significantly affects quality of life. This study aims to address this issue by enhancing patients' physical conditioning and adherence to pre- and postoperative rehabilitation through the use of wearable devices and remote physiotherapy consultations.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 40
Maximum Age: 80
Healthy Volunteers: f
View:
• Biopsy-confirmed localized prostate cancer (ICD code C.61).
• Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND).
• Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter.
• No known urethral stricture or colostomy or chronic urinary catheterization.
• No medical or current psychiatric disorders that precludes their participation in the study.
• Status of the musculoskeletal system allowing physical exercise.
• Urinary continent at baseline.
• Has reliable internet and the skills/knowledge to use technologies use for the study.
Contact Information
Primary
Petra Bastlová, Ph.D.
Petra.Bastlova@fnol.cz
+420 588 442 628
Time Frame
Start Date:2026-06-01
Estimated Completion Date:2028-09-30
Participants
Target number of participants:200
Treatments
Experimental: Telemedicine-Supported Prehabilitation and Rehabilitation
Preoperative Phase:~Wearable Technology: Smartwatch monitoring steps, heart rate, and activity. Physical Exam \& Physiotherapy Session: Musculoskeletal evaluation, pelvic floor training via sonographic feedback, posture/respiratory exercises (2-4 weeks pre-surgery).~Activity Guidelines: Specific daily step targets and exercises to optimize surgical readiness.~Educational Support: Videos demonstrating pelvic floor training, posture, breathing, and exercises.~Remote Monitoring \& Notifications: Continuous monitoring with inactivity alerts/reminders.~Online Consultations: Virtual physiotherapy sessions for feedback and plan adjustments.~Postoperative Phase:~Physiotherapy Visits: At 3, 4, 6 weeks; 3, 6 months post-surgery for assessment and rehab adjustments.~Telemonitoring: Continued wearable monitoring, video consultations, and access to educational videos.~Data Collection: Objective wearable data collected to track progress, adherence, and personalize rehab.
No_intervention: Control Group (Standard Preoperative and Postoperative Care)
Preoperative Phase:~Wearable Technology: Participants receive wearable devices (smartwatch, tablet or phone) for real-time monitoring of physical activity parameters (step count, heart rate, general activity).~Physical Exam \& Physiotherapy: Physiotherapist evaluates musculoskeletal function, provides verbal education on pelvic floor muscle activity, posture, and respiratory exercises; scheduled 2-4 weeks pre-surgery.~Printed Educational Material: Participants receive printed booklets containing general information, exercises, and activity guidelines to prepare for surgery.~Telemonitoring (No Notifications): Activity digitally monitored, without sending reminders or prompts for exercise adherence.~Postoperative Phase:~Physiotherapy Visits: Scheduled at 3 weeks, 4 weeks, 6 weeks, 3 months, and 6 months post-surgery for progress assessment and rehabilitation adjustments.~Data Collection: Continuous collection of objective data from wearable devices compared to intervention group.